Illustrative image – not actual.
GSK Pharmaceuticals is undertaking a Rs 500 crore upgradation of its Nashik unit to expand its portfolio of thyroid and dermatology products. This investment is in addition to Rs 1,000 crore investment for a greenfield plant in Bengaluru.
The plant in Bengaluru will be ready by 2017 end and will have a capacity for eight billion tablets and a billion capsules annually. The construction is being funded through internal accruals.
The government is also commiting Rs 500 crore each for a technology upgradtion fund to support small pharma units and setting up three additional National Institute of Pharmaceutical Education and Research's centres.
